Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment Ferrari, Serge Livio; Butler, Peter W; Kendler, David L; Miller, Paul D; ... Lewiecki, E Michael 2019
add to browser selection
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension Cummings, Steven R; Ferrari, Serge Livio; Eastell, Richard; Gilchrist, Nigel; ... Brown, Jacques P 2018
add to browser selection
Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment Hiligsmann, Mickaël; Dellaert, Benedict G.; Dirksen, Carmen D.; Watson, Verity; ... Boonen, Annelies 2017
add to browser selection
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis McClung, Michael R; Boonen, Steven; Törring, Ove; Roux, Christian; ... Cummings, Steven R 2012
add to browser selection
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis Tubiana-Hulin, Michèle; Spielmann, Marc; Roux, Christian; Campone, Mario; ... Namer, Moïse 2009